
Religare Enterprises (RELIGARE) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
16.1B
Net Income
1.5B
9.38%
Balance Sheet Metrics
Total Assets
112.3B
Total Liabilities
77.9B
Shareholders Equity
34.4B
Debt to Equity
2.27
Cash Flow Metrics
Revenue & Profitability Trend
Religare Enterprises Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 59.1B | 47.7B | 37.3B | 24.5B | 16.8B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 2.6B | - | 3.8B | 2.5B |
Other Operating Expenses | 45.6B | 1.6B | 28.4B | 22.3B | 2.3B |
Total Operating Expenses | 45.6B | 4.2B | 28.4B | 26.1B | 4.8B |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | - | - | - |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 2.4B | 4.5B | 32.6B | -10.3B | -5.0B |
Income Tax | 599.8M | 1.0B | 900.2M | 5.1B | -196.4M |
Effective Tax Rate % | 24.7% | 22.4% | 2.8% | 0.0% | 0.0% |
Net Income | 1.8B | 3.5B | 31.7B | -15.4B | -4.8B |
Net Margin % | 3.1% | 7.3% | 85.1% | -62.8% | -28.4% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | ₹3.79 | ₹7.13 | ₹96.06 | ₹-51.33 | ₹-19.65 |
EPS (Diluted) | ₹3.78 | ₹7.07 | ₹94.67 | ₹-51.33 | ₹-19.69 |
Basic Shares Outstanding | 330325330 | 326706819 | 320808474 | 300770836 | 258748947 |
Diluted Shares Outstanding | 330325330 | 326706819 | 320808474 | 300770836 | 258748947 |
Income Statement Trend
Religare Enterprises Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 10.9B | 4.3B | 8.1B | 25.3B | 8.3B |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.1B | 76.8M | 1.5B | 43.4M | 40.4M |
Goodwill | 468.3M | 574.5M | 599.3M | 623.3M | 688.7M |
Intangible Assets | 273.9M | 340.2M | 404.9M | 428.9M | 494.3M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 112.3B | 95.8B | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 14.4B | 8.2B | 3.2B | 18.8B | 11.3B |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 2.3B | 4.4B | 8.4B | 47.9B | 48.6B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 77.9B | 64.0B | - | - | - |
Equity | |||||
Common Stock | 3.3B | 3.3B | 3.2B | 3.2B | 2.6B |
Retained Earnings | - | -41.4B | - | -67.6B | -53.8B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 34.4B | 31.7B | 26.8B | -5.3B | 3.0B |
Key Metrics | |||||
Total Debt | 2.3B | 4.4B | 8.4B | 47.9B | 48.6B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Religare Enterprises Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 2.4B | 4.5B | 32.6B | -10.3B | -5.0B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 909.0K | -7.3M | -50.3M | 45.1M | -63.7M |
Working Capital Changes | 8.3B | 253.9M | 1.2B | 1.4B | -764.7M |
Operating Cash Flow | 4.7B | -1.7B | 3.4B | -3.9B | -625.9M |
Investing Activities | |||||
Capital Expenditures | -245.6M | -210.4M | -396.6M | -390.0M | -177.3M |
Acquisitions | 0 | -30.0M | 0 | 0 | 0 |
Investment Purchases | -27.4B | -22.8B | -23.2B | -19.5B | -24.8B |
Investment Sales | 8.5B | 7.3B | 9.8B | 12.8B | 13.2B |
Investing Cash Flow | -18.2B | -18.4B | -12.8B | -9.2B | -13.6B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | 0 | 150.0M |
Debt Repayment | - | - | -21.3B | -635.4M | -4.7B |
Financing Cash Flow | 108.4M | 1.6B | -20.1B | 6.7B | -439.7M |
Free Cash Flow | 15.5B | 14.8B | 14.7B | 15.6B | 13.5B |
Net Change in Cash | -13.4B | -18.5B | -29.5B | -6.3B | -14.7B |
Cash Flow Trend
Religare Enterprises Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
67.60
Price to Book
3.34
Price to Sales
1.14
PEG Ratio
-1.44
Profitability Ratios
Profit Margin
1.69%
Operating Margin
11.17%
Return on Equity
5.55%
Return on Assets
1.69%
Financial Health
Current Ratio
0.75
Debt to Equity
6.79
Beta
-0.51
Per Share Data
EPS (TTM)
₹3.77
Book Value per Share
₹76.19
Revenue per Share
₹223.93
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
religare | 84.4B | 67.60 | 3.34 | 5.55% | 1.69% | 6.79 |
Life Insurance | 5.8T | 11.82 | 5.08 | 37.90% | 6.20% | 0.00 |
SBI Life Insurance | 1.8T | 74.08 | 10.30 | 14.90% | 2.05% | 0.00 |
Niva Bupa Health | 147.6B | 105.25 | 4.44 | 4.75% | 2.01% | 7.71 |
HDFC Life Insurance | 1.6T | 86.93 | 9.65 | 11.61% | 1.89% | 17.31 |
ICICI Prudential | 872.5B | 69.67 | 6.96 | 10.59% | 1.78% | 20.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.